Valuation: BioNote, Inc.

Market Cap 466B 301M 264M 243M 226M 427M 28.62B 436M 2.92B 1.13B 14.01B 1.13B 1.1B 48.98B P/E 2024
8.69x
P/E 2025 -6.32x
Enterprise Value 130B 83.74M 73.61M 67.77M 63.09M 119M 7.97B 122M 815M 316M 3.9B 314M 308M 13.65B EV / Sales 2024
0.77x
EV / Sales 2025 1.84x
Free-Float
12.55%
Yield 2024
4.25%
Yield 2025 -
1 day+1.10%
1 week+5.26%
Current month+1.10%
1 month-5.83%
3 months-8.99%
6 months-15.81%
Current year-15.81%
1 week 4,240
Extreme 4240
4,630
1 month 4,240
Extreme 4240
4,990
Current year 4,240
Extreme 4240
6,260
1 year 4,240
Extreme 4240
6,320
3 years 3,800
Extreme 3800
6,460
5 years 3,800
Extreme 3800
11,700
10 years 3,800
Extreme 3800
11,700
Manager TitleAgeSince
Chief Executive Officer 58 2020-07-31
Director of Finance/CFO 54 2021-03-31
Sales & Marketing 39 2025-03-25
Director TitleAgeSince
Chairman 65 2023-02-28
Director/Board Member 58 2020-07-31
Director/Board Member 50 -
Date Insider Type Main position Quantity % Market Cap.
25-02-04Don

Chairman

10,000,000 9.8058%
25-02-04Free 10,000,000 9.8058%
24-04-13Others 6,729,843 6.5991%
Change 5-day change 1-year change 3-year change Capi.($)
+1.10%+5.26%-8.63%+1.21% 298M
-3.02%+12.59%-10.95%-29.81% 3.28B
+1.28%+5.45%+6.43%-84.11% 1.9B
+3.04%+0.20%-42.94% - 51.01M
Average +0.60%+6.90%-14.02%-37.57% 1.38B
Weighted average by Cap. -1.27%+11.20%-5.15%-46.94%

Financials

2024 2025
Net sales 103B 66.29M 58.28M 53.65M 49.95M 94.25M 6.31B 96.2M 645M 250M 3.09B 249M 243M 10.8B 118B 76.32M 67.09M 61.76M 57.51M 109M 7.27B 111M 742M 288M 3.56B 287M 280M 12.44B
Net income 55.26B 35.64M 31.33M 28.85M 26.86M 50.67M 3.39B 51.72M 347M 134M 1.66B 134M 131M 5.81B -87.5B -56.44M -49.61M -45.67M -42.52M -80.24M -5.37B -81.9M -549M -213M -2.63B -212M -207M -9.2B
Net Debt -401B -259M -228M -210M -195M -368M -24.66B -376M -2.52B -977M -12.07B -972M -951M -42.2B -336B -217M -191M -175M -163M -308M -20.65B -315M -2.11B -818M -10.11B -814M -796M -35.33B
Logo BioNote, Inc.
BioNote Inc is a Korea-based company principally engaged in the bio-contents business. The Company is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The Company is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.
Employees
298
Date Price Change Volume
26-07-01 ₩4,605.00 +1.10% 64,956
26-06-30 ₩4,555.00 +1.00% 40,624
26-06-29 ₩4,510.00 +3.32% 109,363
26-06-26 ₩4,365.00 -1.69% 82,218
26-06-25 ₩4,440.00 -0.22% 86,058
  1. Stock Market
  2. Stocks
  3. A377740 Stock